Related Experiment Videos
How MHC class II molecules reach the endocytic pathway
P Bénaroch1, M Yilla, G Raposo
1Department of Biology, Massachussetts Institute of Technology, Cambridge 02139.
The EMBO Journal
|January 3, 1995
Summary
Human B cells treated with concanamycin B show altered major histocompatibility complex (MHC) class II trafficking. The invariant chain (Ii) remains bound, preventing peptide loading and altering surface expression of MHC class II molecules.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Major histocompatibility complex (MHC) class II molecules present antigens to T helper cells.
- Invariant chain (Ii) is crucial for proper folding, assembly, and trafficking of MHC class II molecules.
- Vacuolar H(+)-ATPases are essential for endosomal acidification and protein maturation.
Purpose of the Study:
- To investigate the trafficking of MHC class II molecules in human B cells under conditions of inhibited vacuolar acidification.
- To determine the role of vacuolar H(+)-ATPases in the processing and surface expression of MHC class II-Ii complexes.
Main Methods:
- Treatment of human B cells with concanamycin B, a specific inhibitor of vacuolar H(+)-ATPases.
- Biochemical and morphological analyses to assess protein association and cellular localization.
- Flow cytometry to quantify surface expression of MHC class II molecules.
Main Results:
- Concanamycin B treatment prevented invariant chain (Ii) breakdown and the conversion of MHC class II molecules to peptide-loaded dimers.
- MHC class II-Ii complexes accumulated intracellularly.
- A minor but significant increase in surface expression of MHC class II-Ii complexes was observed, suggesting alternative trafficking routes.
Conclusions:
- The majority of newly synthesized MHC class II-Ii complexes are targeted directly from the trans-Golgi network to the peptide-loading compartment.
- The cell surface and early endosomes are largely bypassed in the primary trafficking pathway of MHC class II molecules.
- Vacuolar acidification is critical for the efficient processing and presentation of MHC class II-bound peptides.